UBS Group
SHC icon

UBS Group’s Sotera Health SHC Stock Holding History

UBS Group’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Buy
1,321,766
+961,935
+267% +$15.2M ﹤0.01% 2516
2026
Q1 		$5.16M Sell
359,831
-81,680
-19% -$1.36M ﹤0.01% 4055
2025
Q4 		$7.79M Sell
441,511
-67,754
-13% -$1.12M ﹤0.01% 3556
2025
Q3 		$8.01M Sell
509,265
-905,402
-64% -$12.7M ﹤0.01% 3537
2025
Q2 		$15.7M Buy
1,414,667
+54,795
+4% +$642K ﹤0.01% 2628
2025
Q1 		$15.9M Sell
1,359,872
-107,001
-7% -$1.38M ﹤0.01% 2578
2024
Q4 		$20.1M Buy
1,466,873
+1,232,373
+526% +$17.9M ﹤0.01% 2315
2024
Q3 		$3.92M Buy
234,500
+111,283
+90% +$1.63M ﹤0.01% 3329
2024
Q2 		$1.46M Buy
123,217
+6,312
+5% +$72.1K ﹤0.01% 4064
2024
Q1 		$1.4M Buy
116,905
+116,545
+32,374% +$1.73M ﹤0.01% 4297
2023
Q4 		$6.07K Sell
360
-3,432
-91% -$48.6K ﹤0.01% 7730
2023
Q3 		$56.8K Sell
3,792
-129
-3% -$2.18K ﹤0.01% 6216
2023
Q2 		$73.9K Sell
3,921
-90,810
-96% -$1.44M ﹤0.01% 6228
2023
Q1 		$1.7M Buy
94,731
+13,057
+16% +$218K ﹤0.01% 3598
2022
Q4 		$680K Buy
81,674
+81,325
+23,302% +$607K ﹤0.01% 4425
2022
Q3 		$2K Sell
349
-63,431
-99% -$1.05M ﹤0.01% 9772
2022
Q2 		$1.25M Sell
63,780
-30,301
-32% -$635K ﹤0.01% 3540
2022
Q1 		$2.04M Buy
94,081
+74,941
+392% +$1.59M ﹤0.01% 3398
2021
Q4 		$451K Sell
19,140
-119
-0.6% -$2.85K ﹤0.01% 5061
2021
Q3 		$504K Buy
19,259
+15,830
+462% +$383K ﹤0.01% 4730
2021
Q2 		$83K Sell
3,429
-7,366
-68% -$181K ﹤0.01% 6025
2021
Q1 		$269K Buy
10,795
+8,882
+464% +$235K ﹤0.01% 5276
2020
Q4 		$52K Buy
+1,913
New +$51.4K ﹤0.01% 6151

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

UBS Group's SHC Position: Q2 2026 in Review

UBS Group increased its Sotera Health (SHC) stake by 267% in Q2 2026, buying an estimated $15.2M and bringing the position to 1,321,766 shares worth $23.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

UBS Group first reported a position in SHC in Q4 2020 and has held it in 23 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • UBS Group held 1,321,766 shares of Sotera Health worth $23.5M as of Q2 2026.
  • UBS Group bought 961,935 Sotera Health shares in Q2 2026, an estimated $15.2M.
  • Sotera Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2516 holding.
  • UBS Group first reported a position in Sotera Health in Q4 2020 and has held it in 23 quarters since.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.